Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane Review

By Albuquerque L.E.T.  

Human Reproduction, Vol. 18, Iss. 10, 2003-10 ,pp. : 2008-2017

Oxford University Press

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite

A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

By Out Henk J.  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

Effect of duration of the GnRH agonists in the luteal phase in the outcome of assisted reproduction cycles

By Geber Selmo   Sampaio Marcos  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 608-610

Informa Healthcare

Access to resources Recommend Favorite

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

By Ragni G.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2421-2425

Oxford University Press

Access to resources Recommend Favorite